A 62-year-old with HFrEF (EF 30%) on furosemide and metoprolol presents for optimization. According to current guidance, which foundational therapy set improves mortality?AARNI (sacubitril/valsartan), evidence-based beta-blocker, mineralocorticoid receptor antagonist, and SGLT2 inhibitorBACE inhibitor alone at target doseCDigoxin and loop diureticDNitrate and hydralazine for all patients regardless of raceENon-dihydropyridine calcium channel blocker and diureticCheck my answer